India vs Nigeria: The number of people with susceptibility test result for rifampicin
India
76.27
in 2021
Nigeria
76
in 2021
India rank
98th
Nigeria rank
100th
The number of people with susceptibility test result for rifampicin over time
- India
- Nigeria
How they compare
India currently reports 76.27 against 76 in Nigeria, a difference of 0.27.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was India ahead.
India ranks 98th and Nigeria ranks 100th of 146 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.98 | 48.49 | 3.48 | India |
| 2020s | 87.02 | 71.34 | 15.67 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, India or Nigeria?
- India, at 76.27 against 76 in Nigeria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between India and Nigeria?
- 0.27, with India ahead.
- How many years of comparable data are there for India and Nigeria?
- 5 years are reported by both, from 2017 to 2021.
- How do India and Nigeria rank globally for the number of people with susceptibility test result for rifampicin?
- India ranks 98th and Nigeria ranks 100th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.